Vertex Pharmaceuticals Incorporated

The Inflation Reduction Act (IRA)’s $2,000 Part D spending cap, which took effect on 1 January, is projected to help more than 11 million Medicare beneficiaries save $7bn on prescription drugs, accord

Opioids have been a dominant, but problematic, drug class in pain for decades, so the approval of the first non-opioid acute pain drug earlier this year helped boost investor interest in the space. La

US Centers for Medicare and Medicaid Services Administrator nominee Mehmet Oz is committed to defending the Medicare price negotiation program, but will pursue other ways to lower drug costs if confir

Entering 2025, biopharma industry observers expected an uptick of merger-and-acquisition activity, coming off a 2024 that saw some historic lows for such activity. Hopes were raised with some sizeab